openPR Logo
Press release

Immunoglobulin Market Size to Reach USD 25.8 Billion by 2033 | With a 4.70% CAGR

12-06-2024 10:15 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: IMARC Group

Immunoglobulin Market

Immunoglobulin Market

๐†๐ฅ๐จ๐›๐š๐ฅย ๐ˆ๐ฆ๐ฆ๐ฎ๐ง๐จ๐ ๐ฅ๐จ๐›๐ฎ๐ฅ๐ข๐งย ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ญ๐š๐ญ๐ข๐ฌ๐ญ๐ข๐œ๐ฌ: ๐”๐’๐ƒ ๐Ÿ๐Ÿ“.๐Ÿ– ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐•๐š๐ฅ๐ฎ๐ž ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ‘

๐’๐ฎ๐ฆ๐ฆ๐š๐ซ๐ฒ:

โ— The global immunoglobulin market size reached USD 16.5 Billion in 2024.
โ— The market is expected to reach USD 25.8 Billion by 2033, exhibiting a growth rate (CAGR) of 4.70% during 2025-2033.
โ— North America leads the market, accounting for the largestย immunoglobulin industry share.
โ— IgG accounts for the majority of the market share in the product segment due to IgG's effectiveness and safety profile.
โ— Immunodeficiency disease holds the largest share in the immunoglobulin industry.
โ— Intravenous mode of delivery remains a dominant segment in the market owing to the established protocols and healthcare infrastructure for intravenous administration.
โ— The rising prevalence of immunodeficiency diseases is a primary driver of the immunoglobulin market.
โ— The increasing Awareness and diagnosis of immunodeficiency diseases is reshaping the immunoglobulin market.

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐Ÿ๐จ๐ซ ๐š ๐ฌ๐š๐ฆ๐ฉ๐ฅ๐ž ๐œ๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐ญ๐ก๐ข๐ฌ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ:ย https://www.imarcgroup.com/immunoglobulin-market/requestsample

๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐“๐ซ๐ž๐ง๐๐ฌ ๐š๐ง๐ ๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ:

โ— ๐‘๐ข๐ฌ๐ข๐ง๐  ๐ฉ๐ซ๐ž๐ฏ๐š๐ฅ๐ž๐ง๐œ๐ž ๐จ๐Ÿ ๐ข๐ฆ๐ฆ๐ฎ๐ง๐จ๐๐ž๐Ÿ๐ข๐œ๐ข๐ž๐ง๐œ๐ฒ ๐๐ข๐ฌ๐ž๐š๐ฌ๐ž๐ฌ:

For this reason, when the general prevalence of PIDDs and SID rises in any society, there is always a demand for immunoglobulin therapies for the diseases. However in any occasion there is an immune system disease, immunoglobulin therapies are essential because it is helpful to bring along antibodies which are an important culprit in fighting diseases. This leads to frequent application of immunoglobulin products since it is used in such basic functions as prevention of occurrence of diseases in a more permanent basis. Other advancement in this area is increase in the identification and analysation of diagnosis procedures increase early detection of immunodeficiency diseases. This leads to first-line treatment of potential disease expressions with immunoglobulin products, thereby fortifying the stoke of product market demand. A vast majority of immunodeficiency patients need intravenous immunoglobulin in their entire lifetime, therefore guaranteeing stable high market prospects in the future. This makes them to always generate revenued because it is a chronic treatment factor.

โ— ๐€๐ ๐ข๐ง๐  ๐๐จ๐ฉ๐ฎ๐ฅ๐š๐ญ๐ข๐จ๐ง:

For instance the health of elderly population has been worsened through bad immune system mechanisms whereby the elderly get diseases and recurring diseases. The demographic particularly needs more immunoglobulin therapies because the treatment helped in enhancing its immunity. This group of people also has pre dispositions to various ailments and conditions that are rife with old age such as diabetic conditions, cardiac conditions, auto immune diseases among others. Administration of immunoglobulin is more in complication from these diseases hence; there is rising use of immunoglobulin. Many diseases that are widespread among older populations: Immunoglobulin is required in cases of Alzheimer's disease, Parkinson's disease, malignant tumors and so on. This population usually requires chronic diseases for which, in most cases, immunoglobulin treatment is necessary. The fact that immunoglobulin products require constant maintenance treatment is advantageous because it establishes a more stable and hence easier to manage business.

โ— ๐ˆ๐ง๐œ๐ซ๐ž๐š๐ฌ๐ข๐ง๐  ๐€๐ฐ๐š๐ซ๐ž๐ง๐ž๐ฌ๐ฌ ๐š๐ง๐ ๐๐ข๐š๐ ๐ง๐จ๐ฌ๐ข๐ฌ:

Immunodeficiency diseases are more familiar to doctors and the public, and therefore are diagnosed at an earlier stage. Early intervention with immunoglobulin therapies is essential and demanded. Increased assistance seeking by informed patients raises both diagnoses, and therefore the size of the treatment group. Dental doctors have received training throughout the years as an effort to correctly diagnose their patient and come out with better treatment thus increasing the prescription for therapy. Many immunodeficiency disorders have become easily diagnosed using the latest diagnostic tools, and thus more patients are being treated.

๐๐ฎ๐ฒ ๐…๐ฎ๐ฅ๐ฅ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:ย https://www.imarcgroup.com/checkout?id=4505&method=502

๐ˆ๐ฆ๐ฆ๐ฎ๐ง๐จ๐ ๐ฅ๐จ๐›๐ฎ๐ฅ๐ข๐ง ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง:

๐๐ซ๐ž๐š๐ค๐ฎ๐ฉ ๐๐ฒ ๐๐ซ๐จ๐๐ฎ๐œ๐ญ:

โ— IgG
โ— IgA
โ— IgM
โ— IgE
โ— IgD

IgG represents the largest segment as IgG is the most abundant immunoglobulin in human serum and is widely used for various therapeutic applications.

๐๐ซ๐ž๐š๐ค๐ฎ๐ฉ ๐๐ฒ ๐€๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง:

โ— Hypogammaglobulinemia
โ— Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
โ— Immunodeficiency Disease
โ— Myasthenia Gravis
โ— Others

Immunodeficiency disease accounts for the majority of the market share. Immunodeficiency diseases require ongoing treatment with immunoglobulin therapies, resulting in a substantial demand that accounts for a significant portion of market share.

๐๐ซ๐ž๐š๐ค๐ฎ๐ฉ ๐๐ฒ ๐Œ๐จ๐๐ž ๐จ๐Ÿ ๐ƒ๐ž๐ฅ๐ข๐ฏ๐ž๐ซ๐ฒ:

โ— Intravenous Mode of Delivery
โ— Subcutaneous Mode of Delivery

Intravenous mode of delivery exhibits a clear dominance in the market due to its rapid administration and higher plasma levels of immunoglobulin, making it the preferred method for many clinicians and patients.

๐๐ซ๐ž๐š๐ค๐ฎ๐ฉ ๐๐ฒ ๐‘๐ž๐ ๐ข๐จ๐ง:

โ— North America (United States, Canada)
โ— Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
โ— Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
โ— Latin America (Brazil, Mexico, Others)
โ— Middle East and Africa

North America enjoys the leading position in the immunoglobulin market on account of its well-established healthcare infrastructure, higher prevalence of immunodeficiency diseases, and greater access to advanced treatment options.

๐€๐ฌ๐ค ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ญ ๐Ÿ๐จ๐ซ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:ย https://www.imarcgroup.com/request?type=report&id=4505&flag=C

๐“๐จ๐ฉย ๐ˆ๐ฆ๐ฆ๐ฎ๐ง๐จ๐ ๐ฅ๐จ๐›๐ฎ๐ฅ๐ข๐ง ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‹๐ž๐š๐๐ž๐ซ๐ฌ:

The immunoglobulin market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies. Some of the key players in the market are:

โ— ADMA Biologics Inc.
โ— Baxter international Inc.
โ— Biotest AG
โ— CSL Limited
โ— Grifols S.A
โ— Kedrion S.p.A
โ— LFB SA
โ— Octapharma AG
โ— Sanquin Plasma Products B.V.
โ— Takeda Pharmaceutical Company Limited

๐๐จ๐ญ๐ž: ๐ˆ๐Ÿ ๐ฒ๐จ๐ฎ ๐ซ๐ž๐ช๐ฎ๐ข๐ซ๐ž ๐š๐ง๐ฒ ๐ฌ๐ฉ๐ž๐œ๐ข๐Ÿ๐ข๐œ ๐ข๐ง๐Ÿ๐จ๐ซ๐ฆ๐š๐ญ๐ข๐จ๐ง ๐ญ๐ก๐š๐ญ ๐ข๐ฌ ๐ง๐จ๐ญ ๐œ๐จ๐ฏ๐ž๐ซ๐ž๐ ๐œ๐ฎ๐ซ๐ซ๐ž๐ง๐ญ๐ฅ๐ฒ ๐ฐ๐ข๐ญ๐ก๐ข๐ง ๐ญ๐ก๐ž ๐ฌ๐œ๐จ๐ฉ๐ž ๐จ๐Ÿ ๐ญ๐ก๐ž ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ, ๐ฐ๐ž ๐ฐ๐ข๐ฅ๐ฅ ๐ฉ๐ซ๐จ๐ฏ๐ข๐๐ž ๐ญ๐ก๐ž ๐ฌ๐š๐ฆ๐ž ๐š๐ฌ ๐š ๐ฉ๐š๐ซ๐ญ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐œ๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐š๐ญ๐ข๐จ๐ง.

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐”๐ฌ:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Immunoglobulin Market Size to Reach USD 25.8 Billion by 2033 | With a 4.70% CAGR here

News-ID: 3775697 • Views: โ€ฆ

More Releases from IMARC Group

Global Luxury Cosmetics Market Set for Remarkable Growth with Rising Demand for Premium Beauty Products
Global Luxury Cosmetics Market Set for Remarkable Growth with Rising Demand for โ€ฆ
The global luxury cosmetics market reached a valuation of USD 54.9 billion in 2024, reflecting strong momentum across beauty and skincare categories. Growth in this sector is driven by rising disposable incomes, particularly in emerging economies, and an increasing preference for premium beauty products that emphasize exclusivity and superior quality. Additionally, social media engagement and digital influence have reshaped consumer choices, motivating buyers to explore luxury cosmetic brands and high-endโ€ฆ
Global E-Invoicing Market Set for Robust Expansion Driven by Digital Transformation and Compliance Needs
Global E-Invoicing Market Set for Robust Expansion Driven by Digital Transformat โ€ฆ
Market Overview The global e-invoicing market was valued at USD 15.9 billion in 2024 and is projected to reach USD 68.7 billion by 2033, expanding at a CAGR of 16.8% during 2025-2033. This strong growth is driven by the rapid rise of e-commerce, acceleration of digital transformation across industries, advancements in cloud-based platforms, and increasing government regulations that promote financial transparency and sustainable practices. With automation and digital invoicing becoming standardโ€ฆ
Global Governance, Risk and Compliance Platform Market Set for Robust Growth Driven by Rising Regulatory Demands
Global Governance, Risk and Compliance Platform Market Set for Robust Growth Dri โ€ฆ
Governance, Risk, and Compliance Platform Market Overview The global governance, risk, and compliance platform market was valued at USD 49.2 billion in 2024 and is projected to surge to USD 127.7 billion by 2033, advancing at a CAGR of 11.18%. This robust growth is driven by rapid regulatory changes, rising cybersecurity risks, and the widespread adoption of hybrid and remote work models. Organizations are increasingly adopting advanced GRC platforms powered by cloudโ€ฆ
Barley Prices July 2025 - Trend, Chart, Index & Forecast
Barley Prices July 2025 - Trend, Chart, Index & Forecast
North America Barley Prices Movement Q3 July 2025: In July 2025, barley prices in North America were recorded at 1.05 USD/KG, reflecting a 1.0% decline. The downward movement was driven by ample domestic supply and favourable harvest conditions. Slower export demand and competitive global pricing added pressure, while transportation and storage costs remained relatively stable across the region. Regional Analysis: The price analysis can be extended to provide detailed EPDM Rubber priceโ€ฆ

All 5 Releases


More Releases for Immunoglobulin

Key Subcutaneous Immunoglobulin (SCIG) Market Trend for 2025-2034: Advancements โ€ฆ
What Is the Future Outlook for the Subcutaneous Immunoglobulin (SCIG) Market's Size and Growth Rate? There has been a rapid expansion in the subcutaneous immunoglobulin (SCIG) market size in the previous years. It's projected to swell from $12.72 billion in 2024 to $14.52 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 14.1%. The upsurge in the past era is credited to the heightened occurrence of immunodeficiency disorders,โ€ฆ
Intravenous Immunoglobulin Market CAGR of intravenous immunoglobulin market is t โ€ฆ
The report is designed to provide a holistic view of the Intravenous Immunoglobulin Market .It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; revenue, demands, and supply data (as applicable). Regional estimates and forecasts & trend analysis for eac country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Luxemburg, Rest of Europe, Japan, China, Southโ€ฆ
Boosting Immunity: Innovations in Subcutaneous Immunoglobulin (SCIG)
The Business Research Company recently released a comprehensive report on the Global Subcutaneous Immunoglobulin (SCIG) Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Yourโ€ฆ
Intravenous Immunoglobulin Market CAGR of intravenous immunoglobulin market is t โ€ฆ
The report is designed to provide a holistic view of the Intravenous Immunoglobulin Market . It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; revenue, demands, and supply data (as applicable). Regional estimates and forecasts & trend analysis for eac country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Luxemburg, Rest of Europe, Japan, China,โ€ฆ
Korea Intravenous Immunoglobulin Market Analysis to 2031
Intravenous Immunoglobulin Market Outlook 2031 Theย global intravenous immunoglobulin marketย was valued atย US$ 11.2 Bnย inย 2021 It is estimated to grow at a CAGR ofย 7.3%ย from 2022 to 2031 Theย global intravenous immunoglobulin marketย is expected to reach value ofย US$ 20.5 Bnย by the end ofย 2031 Get Sample Copy of the Report@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1930 Overview of Intravenous Immunoglobulin Market Immunoglobulins are highly purified, sterile-specific medical therapy solutions containing gamma globulin G (IgG) in a concentration of 95% or more. These are manufactured from a highlyโ€ฆ
Immunoglobulin Market 2021 | Detailed Report
Global Immunoglobulin Market 2021-2027, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample PDF (including full TOC, Tables and Figures) ofโ€ฆ